146 related articles for article (PubMed ID: 33041341)
1. IL-33/ST2 signaling in liver transplantation.
Tan Z; Sun B
Cell Mol Immunol; 2021 Mar; 18(3):761-763. PubMed ID: 33041341
[No Abstract] [Full Text] [Related]
2. Ablation of interaction between IL-33 and ST2+ regulatory T cells increases immune cell-mediated hepatitis and activated NK cell liver infiltration.
Noel G; Arshad MI; Filliol A; Genet V; Rauch M; Lucas-Clerc C; Lehuen A; Girard JP; Piquet-Pellorce C; Samson M
Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G313-23. PubMed ID: 27340126
[TBL] [Abstract][Full Text] [Related]
3. IL-33/ST2 pathway drives regulatory T cell dependent suppression of liver damage upon cytomegalovirus infection.
Popovic B; Golemac M; Podlech J; Zeleznjak J; Bilic-Zulle L; Lukic ML; Cicin-Sain L; Reddehase MJ; Sparwasser T; Krmpotic A; Jonjic S
PLoS Pathog; 2017 Apr; 13(4):e1006345. PubMed ID: 28448566
[TBL] [Abstract][Full Text] [Related]
4. IL-33 induces both regulatory B cells and regulatory T cells in dextran sulfate sodium-induced colitis.
Zhu J; Xu Y; Zhu C; Zhao J; Meng X; Chen S; Wang T; Li X; Zhang L; Lu C; Liu H; Sun X
Int Immunopharmacol; 2017 May; 46():38-47. PubMed ID: 28258042
[TBL] [Abstract][Full Text] [Related]
5. The IL-33/ST2 axis is specifically required for development of adipose tissue-resident regulatory T cells.
Hu ZQ; Zhao WH
Cell Mol Immunol; 2015 Sep; 12(5):521-4. PubMed ID: 26277897
[No Abstract] [Full Text] [Related]
6. T
Pascual-Reguant A; Bayat Sarmadi J; Baumann C; Noster R; Cirera-Salinas D; Curato C; Pelczar P; Huber S; Zielinski CE; Löhning M; Hauser AE; Esplugues E
Mucosal Immunol; 2017 Nov; 10(6):1431-1442. PubMed ID: 28198366
[TBL] [Abstract][Full Text] [Related]
7. IL-33 Receptor-Expressing Regulatory T Cells Are Highly Activated, Th2 Biased and Suppress CD4 T Cell Proliferation through IL-10 and TGFβ Release.
Siede J; Fröhlich A; Datsi A; Hegazy AN; Varga DV; Holecska V; Saito H; Nakae S; Löhning M
PLoS One; 2016; 11(8):e0161507. PubMed ID: 27548066
[TBL] [Abstract][Full Text] [Related]
8. Rorc restrains the potency of ST2+ regulatory T cells in ameliorating intestinal graft-versus-host disease.
Yang J; Ramadan A; Reichenbach DK; Loschi M; Zhang J; Griesenauer B; Liu H; Hippen KL; Blazar BR; Paczesny S
JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30694220
[TBL] [Abstract][Full Text] [Related]
9. The IL-33-ST2-MyD88 axis promotes regulatory T cell proliferation in the murine liver.
Xu L; Li W; Wang X; Zhang L; Qi Q; Dong L; Wei C; Pu Y; Li Y; Zhu J; Zhou S; Liu F; Chen X; Su C
Eur J Immunol; 2018 Aug; 48(8):1302-1307. PubMed ID: 29729112
[TBL] [Abstract][Full Text] [Related]
10. IL-33-mediated IL-13 secretion by ST2+ Tregs controls inflammation after lung injury.
Liu Q; Dwyer GK; Zhao Y; Li H; Mathews LR; Chakka AB; Chandran UR; Demetris JA; Alcorn JF; Robinson KM; Ortiz LA; Pitt BR; Thomson AW; Fan MH; Billiar TR; Turnquist HR
JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30779711
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-derived IL-33 promotes intestinal tumorigenesis in Apc
He Z; Chen L; Souto FO; Canasto-Chibuque C; Bongers G; Deshpande M; Harpaz N; Ko HM; Kelley K; Furtado GC; Lira SA
Sci Rep; 2017 Jul; 7(1):5520. PubMed ID: 28710436
[TBL] [Abstract][Full Text] [Related]
12. The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma.
Zoltowska AM; Lei Y; Fuchs B; Rask C; Adner M; Nilsson GP
Clin Exp Allergy; 2016 Mar; 46(3):479-90. PubMed ID: 26609909
[TBL] [Abstract][Full Text] [Related]
13. The IL-33/ST2 axis: Role in health and disease.
De la Fuente M; MacDonald TT; Hermoso MA
Cytokine Growth Factor Rev; 2015 Dec; 26(6):615-23. PubMed ID: 26271893
[TBL] [Abstract][Full Text] [Related]
14. Effects of IL-33/ST2 pathway in acute inflammation on tissue damage, antioxidative parameters, magnesium concentration and cytokines profile.
Stankovic MS; Janjetovic K; Velimirovic M; Milenkovic M; Stojkovic T; Puskas N; Zaletel I; De Luka SR; Jankovic S; Stefanovic S; Japundzic-Zigon N; Petronijevic ND; Trajkovic V; Trbovich AM
Exp Mol Pathol; 2016 Aug; 101(1):31-7. PubMed ID: 27222019
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Opportunities of Interleukin-33 in the Central Nervous System.
Sun Y; Wen Y; Wang L; Wen L; You W; Wei S; Mao L; Wang H; Chen Z; Yang X
Front Immunol; 2021; 12():654626. PubMed ID: 34079543
[TBL] [Abstract][Full Text] [Related]
16. IL-33-ST2 Axis in Liver Disease: Progression and Challenge.
Sun Z; Chang B; Gao M; Zhang J; Zou Z
Mediators Inflamm; 2017; 2017():5314213. PubMed ID: 29180837
[TBL] [Abstract][Full Text] [Related]
17. Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis.
Pejnovic N; Jeftic I; Jovicic N; Arsenijevic N; Lukic ML
World J Gastroenterol; 2016 Nov; 22(44):9706-9717. PubMed ID: 27956794
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-33: increasing role in dermatological conditions.
Balato A; Raimondo A; Balato N; Ayala F; Lembo S
Arch Dermatol Res; 2016 Jul; 308(5):287-96. PubMed ID: 26969580
[TBL] [Abstract][Full Text] [Related]
19. Pollen/TLR4 Innate Immunity Signaling Initiates IL-33/ST2/Th2 Pathways in Allergic Inflammation.
Li J; Zhang L; Chen X; Chen D; Hua X; Bian F; Deng R; Lu F; Li Z; Pflugfelder SC; Li DQ
Sci Rep; 2016 Oct; 6():36150. PubMed ID: 27796360
[TBL] [Abstract][Full Text] [Related]
20. Regulatory Mechanisms of IL-33-ST2-Mediated Allergic Inflammation.
Takatori H; Makita S; Ito T; Matsuki A; Nakajima H
Front Immunol; 2018; 9():2004. PubMed ID: 30233590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
